Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-19)

In this article we will discuss Durvalumab (Warnings-19)

In this article, we will discuss Durvalumab (Warnings-19). So, let’s get started.

Thyroid Disorders: Durvalumab can cause immune-mediated thyroid disorders. Thyroiditis can present with or without endocrine pathology. Hypothyroidism can follow hyperthyroidism. Initiate hormone replacement therapy for hypothyroidism or institute medical management of hyperthyroidism as clinically indicated. Withhold or discontinue Durvalumab based on the severity

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.